Novartis’ Nicola Redfern joins Celgene to head UK market access

Nicola Redfern has been appointed director of market access at Celgene for the UK and Ireland.

Redfern joins Celgene from Novartis where she was director of communications and external affairs for the Swiss pharma firm's oncology business unit.

At Novartis, she was responsible for health economics and outcomes research, communications, patient advocacy, government affairs and leadership of the field-based NHS development team, and Redfern will fill a similar role at Celgene focusing on the changing NHS landscape.

“I am very excited to join Celgene and bring my experience to the market access team to help continue the great work Celgene has been undertaking to improve patient outcome,” she said.

“There is a true need for new innovative medicines and I look forward to working with the team towards helping more patients receive access to these important treatments.”

Prior to joining Novartis in 2003, Redfern spent four years at Sanofi. This included spells as senior product manager and head of medical education. She has also worked in sales for MSD, Procter & Gamble and Pierre Fabrine.

Samantha Pearce, general manager of Celgene UK and Ireland, said: “We are delighted to welcome Nicola to our growing team at Celgene. Her role reinforces our continued commitment to making our treatments available and accessible to all that need them, particularly given the evolving policy environment.”